PackGene Biotech

An international AAV packaging supplier. Aim to provide efficient, cost-effective, high-quality viral delivery solutions for gene and cell therapy.

[PackGene Biotech @PackGeneBiotech]

𝐀𝐀𝐕 𝐠𝐞𝐧𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐦𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞. 𝐍𝐨𝐫𝐰𝐚𝐲 issued a reimbursement recommendation for 𝐇𝐄𝐌𝐆𝐄𝐍𝐈𝐗. 𝐅𝐨𝐥𝐥𝐨𝐰 𝐏𝐚𝐜𝐤𝐆𝐞𝐧𝐞 𝐨𝐧 𝐋𝐢𝐧𝐤𝐞𝐝𝐢𝐧 https://t.co/s1StC4Qzn7 & 𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 𝐭𝐨 𝐎𝐮𝐫 𝐍𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫.

[PackGene Biotech @PackGeneBiotech]

👏 Meet PackGene at #BSGCT2025 in London!
🗓️June 20
📍Royal Holloway University

Let’s talk AAV, LVV, mRNA, & plasmid innovation with Xisha Huang.

#GeneTherapy #Biotech #CDMO #PackGene

[PackGene Biotech @PackGeneBiotech]

We’re heading to #EACR2025 in Lisbon!
📍Booth #17 
🗓️ June 16–19

Explore our full-service #CRO and #CDMO offerings:
🧬 AAV | Lentivirus | Plasmid | mRNA & LNP

Let’s talk cancer gene therapy innovation.
📩 [email protected]

#GeneTherapy #CancerResearch #Biotech #PackGene

[PackGene Biotech @PackGeneBiotech]

📢 Heading to #BIO2025 in Boston, June 16–19?
Meet PackGene’s CSO, Dr. Xin Swanson, to talk #GeneTherapy innovation.

📍Booth 387 – great science and conversations. Let’s connect!

#AAV #mRNA #Plasmid #CDMO #Biotech

[PackGene Biotech @PackGeneBiotech]

We’re at #NVGCT2025 ⌛️June 10–11 in Lenteren, Netherland!

Stop by the PackGene booth & meet Dr. Heng Hu to learn about our AAV, LVV, mRNA & plasmid platforms.
https://t.co/R3xJH6h8bV

#GeneTherapy #Biotech #mRNA #AAV #PackGene

[Genetic Engineering & Biotechnology News @GENbio]

Conquering the Complexities of AAV Manufacturing: Advances in Efficiency, Scalability, Compliance

GEN talked with several CDMOs and/or CROs about new ways they are addressing AAV manufacturing challenges.

@PackGeneBiotech @CRiverLabs @LonzaGroup #AAV
https://t.co/PK7hBtA1Lt

[PackGene Biotech @PackGeneBiotech]

🚨 PackGene is heading to #AACR2025!
🎯 Visit us at Booth 4346 in Chicago, Apr 25–30
🧬 Discover how our AAV, lentiviral, and mRNA platforms are accelerating cancer research.
🎁 Stop by for a chat, insights, and free swag!
🎓 Academic promo: https://t.co/0srTyJBDEf

#GeneTherapy

[PackGene Biotech @PackGeneBiotech]

24-month data from Beacon Therapeutics' AGTC-501 HORIZON Trial for XLRP now in @AmerAcadOphth! Promising results in gene therapy.
#GeneTherapy #RetinalDisease #XLRP #AAV #Packgene

https://t.co/lhNNnsQF8r

[PackGene Biotech @PackGeneBiotech]

Arbor Biotechnologies closes $73.9M Series C to advance ABO-101 for Primary Hyperoxaluria Type 1 (PH1). This milestone highlights the potential of CRISPR Cas12i2 and signals continued investor confidence in groundbreaking therapies.
#GeneEditing #CRISPR
https://t.co/MBPSAeEEs3

[PackGene Biotech @PackGeneBiotech]

HUGE NEWS! Beam Therapeutics achieves FIRST-EVER clinical genetic correction in AATD trial!
 BEAM-302 shows:
✅ ⬆️ AAT levels (exceeding therapeutic threshold!)
✅ ⬇️ 78% reduction in mutant Z-AAT!
✅ Corrected M-AAT production!
✅ Great safety profile!
https://t.co/mjpEtzh3Qy

[PackGene Biotech @PackGeneBiotech]

Academic Discovery Engine
Accelerate your research from design to delivery with academic-exclusive offers
https://t.co/lq2bZQhqRU

#AAV #ViralVector #CRISPR #ResearchOptimization

[PackGene Biotech @PackGeneBiotech]

🧬This #RareDiseaseDay, we’re breaking barriers in gene therapy!

✅Advancing SPG56 & OTOF hearing loss treatments
🔗No patient left behind. Learn more: https://t.co/QegqsXtg19

#GeneTherapy #RareDiseases #BreakingBarriers #PackGene

[PackGene Biotech @PackGeneBiotech]

Allogene ($ALLO) gets FDA IND clearance for ALLO-329, an allogeneic CAR T for autoimmune diseases.
Phase1 trial starts mid-2025 for lupus, myopathies, & systemic sclerosis. Targets CD19+ B cells & CD70+ T cells. Dagger® tech may eliminate lymphodepletion.
https://t.co/63QzgwOdjT

[PackGene Biotech @PackGeneBiotech]

ELEVIDYS shows sustained benefits for 2 YEARS in ambulatory #DMD patients! Sarepta's EMBARK study delivers promising long-term data. ✨
https://t.co/vxoxjaGf4r

#RareDisease #GeneTherapy #AAV #Packgene #Sarepta

[PackGene Biotech @PackGeneBiotech]

We’re at #PMWC2025! Visit PackGene at Booth A421 to discuss our GMP viral (AAV) and non-viral solutions. Let’s innovate together and shape the future of precision medicine.

Booth A421—see you there!

#GeneTherapy #AAV #PrecisionMedicine #Biotech

[PackGene Biotech @PackGeneBiotech]

Vertex & Orna team up to develop gene therapies for SCD & TDT! $65M upfront to boost RNA-based innovations using Orna's LNP tech. This collab drives progress toward better rare disease treatments.
https://t.co/qMtNvirWxB

#GeneTherapy #SCD #VertexPharma

[PackGene Biotech @PackGeneBiotech]

A Global Alliance to Save Lives: How Two Parents and PackGene Are Redefining What’s Possible in Gene Therapy with Help from Weill Cornell Medicine
Read more👉https://t.co/jDLT7clYZp

Video link: https://t.co/Vd7wxf9x6J

#GeneTherapy

[PackGene Biotech @PackGeneBiotech]

Novartis' OAV101 IT gene therapy shows promise for type II SMA patients aged 2-17! 🚀Favorable Phase III results could expand options for older pediatric patients.
https://t.co/qUMW1vAyKc

#GeneTherapy #SMA #RareDisease

[PackGene Biotech @PackGeneBiotech]

✨Medical Breakthroughs of 2024✨
· Enhertu & Tagrisso redefine cancer care
· GLP-1 meds tackle obesity, heart disease, & sleep apnea
· Lenacapavir: 100% HIV prevention
· New treatments for Duchenne MD, schizophrenia & more
https://t.co/7DTeSxwmcw

#GeneTherapy

[PackGene Biotech @PackGeneBiotech]

GEMMABio raises $34M to advance #GeneTherapy for rare diseases! With strong partnerships and innovative approaches, they’re redefining treatment accessibility.
https://t.co/wiTdRhxugf

#HealthcareInnovation #RareDiseases